Advertisement
UK markets close in 7 hours 10 minutes
  • FTSE 100

    8,054.61
    +30.74 (+0.38%)
     
  • FTSE 250

    19,693.13
    +93.74 (+0.48%)
     
  • AIM

    752.19
    +3.01 (+0.40%)
     
  • GBP/EUR

    1.1570
    -0.0019 (-0.16%)
     
  • GBP/USD

    1.2365
    +0.0015 (+0.12%)
     
  • Bitcoin GBP

    53,453.71
    -30.83 (-0.06%)
     
  • CMC Crypto 200

    1,393.67
    -21.09 (-1.49%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CRUDE OIL

    82.70
    +0.80 (+0.98%)
     
  • GOLD FUTURES

    2,321.00
    -25.40 (-1.08%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,823.04
    +311.35 (+1.89%)
     
  • DAX

    17,982.58
    +121.78 (+0.68%)
     
  • CAC 40

    8,061.87
    +21.51 (+0.27%)
     

Is It Time to Get in on GW Pharmaceuticals While the Price Is Right?

Is It Time to Get in on GW Pharmaceuticals While the Price Is Right?

GW Pharmaceuticals (NASDAQ: GWPH) is a crossbreed: a biotech and a cannabis company. Based in England and founded in 1998, the company's focus is examining various cannabinoid formulations as potential therapeutics. GW Pharmaceuticals's biggest drug is Epidiolex, a liquid, purified form of cannabidiol (CBD).